| Literature DB >> 25889648 |
Haifeng Su1, Juan Jiang2, Qiuli Lu3, Zhao Zhao4, Tian Xie5, Hai Zhao6, Maolin Wang7.
Abstract
Early trials have demonstrated great potential for the use of duckweed (family Lemnaceae) as the next generation of energy plants for the production of biofuels. Achieving this technological advance demands research to develop novel bioengineering microorganisms that can ferment duckweed feedstock to produce higher alcohols. In this study, we used relevant genes to transfer five metabolic pathways of isoleucine, leucine and valine from the yeast Saccharomyces cerevisiae into the bioengineered microorganism Corynebacterium crenatum. Experimental results showed that the bioengineered strain was able to produce 1026.61 mg/L of 2-methyl-1-butanol by fermenting glucose, compared to 981.79 mg/L from the acid hydrolysates of duckweed. The highest isobutanol yields achieved were 1264.63 mg/L from glucose and 1154.83 mg/L from duckweed, and the corresponding highest yields of 3-methyl-1-butanol were 748.35 and 684.79 mg/L. Our findings demonstrate the feasibility of using bioengineered C. crenatum as a platform to construct a bacterial strain that is capable of producing higher alcohols. We have also shown the promise of using duckweed as the basis for developing higher alcohols, illustrating that this group of plants represents an ideal fermentation substrate that can be considered the next generation of alternative energy feedstocks.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25889648 PMCID: PMC4324788 DOI: 10.1186/s12934-015-0199-3
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Figure 1Flowsheet of the design for experimental processes. CE: C. crenatum CICC 20153; Glu: glucose; AHD: acid hydrolysates of duckweed as the fermentation substrate, meaning the products resulting from pretreatment of duckweed with acid hydrolysis.
The bacterial strains and vectors used in the bioengineering of bacteria to produce higher alcohols
|
|
|
|
|---|---|---|
| Strains | ||
| DH5α | F−, φ 80d | Takara: 9057 |
|
|
| CICC 20153 |
| Plasmids | ||
| pSTV29 | pACYC184 ori; Cmr; PLlacO−1: MCS | Takara: 3332 |
| p29-pBL | pBL1ori; Cmr; PLlacO−1: MCS | This study |
| PEC-XK99E | pGA1 Kmr pTrc99A MCS P-trc,lacIq | From CAS |
| pXMJ19 | pBL1ori; Kmr; MCS P-trc, lacIq | From CAS |
| PEC-KA | pGA1 Kmr pTrc99A MCS P-trc, lacIq: | This study |
| p29- AL | pBL1ori; Cmr; PLlacO-1:MCS: | This study |
| p29- ALI | pBL1ori; Cmr; PLlacO-1: | This study |
| p29- ALII | pBL1ori; Cmr; PLlacO-1: | This study |
| p29- BI | pBL1ori; Cmr; PLlacO-1: | This study |
| p29- BII | pBL1ori; Cmr; PLlacO−1: | This study |
| p29- BIII | pBL1ori; Cmr; PLlacO−1: | This study |
| p29- CB | pBL1ori; Cmr; PLlacO−1: | This study |
| p29-DL | pBL1ori; Cmr; PLlacO−1: | This study |
| p29-DLL | pBL1ori; Cmr; PLlacO−1: | This study |
| p29-FL | pBL1ori; Cmr; PLlacO−1: | This study |
SC: S. cerevisiae AH109; LL: Lactococcus lactis subsp. cremoris CICC 1605.
Primers used in the bioengineering of bacteria to produce higher alcohols
|
|
|
|
|---|---|---|
| A1 | LEU2-S | ACATGCATGCGGATGTCTGCCCCTAAGAAGAT |
| LEU2-AS | ACGCGTCGACTTAAGCAAGGATTTTCTTAACTTC | |
| A2 | ILV2-S | ACGCGTCGACAAGGAGCCAGATGATCAGACAATCTACGCT |
| ILV2-AS | CGCGGATCCTCAGTGCTTACCGCCTGTAC | |
| A3 | ILV5-S | CGCGGATCCAAGGAGGCCTCATGTTGAGAACTCAAGCCGC |
| ILV5-AS | GCGAGCTCTTATTGGTTTTCTGGTCTCAACTT | |
| B1 | ILV2-S | AAAACTGCAGATGATCAGACAATCTACGCT |
| ILV2-AS | ACGCGTCGACTCAGTGCTTACCGCCTGTAC | |
| B2 | ILV5-S | ACAGGTCGACAAGGAGGTCATGTTGAGAACTCAAGCCGC |
| ILV5-AS | CGCGGATCCTTATTGGTTTTCTGGTCTCAA | |
| B3 | ILV3-S | CGCGGATCCAAGGAGCTGCATGGGCTTGTTAACGAAAGT |
| ILV3-AS | GCGAGCTCTCAAGCATCTAAAACACAACC | |
| C1 | BAT2-S | CGGCCTGCAGGATGACCTTGGCACCCCTAGA |
| BAT2-AS | CGCGGATCCTCAGTTCAAATCAGTAACAA | |
| D2 | LEU1-S | TCCCCCCGGGAAGGAGACTAATGGTTTACACTCCATCCAA |
| LEU1-AS | GCGAGCTCCTACCAATCCTGGTGGACTTT | |
| C2 | leu1-2as | CGCGGATCCAAAGGAGGCCGCATGGTTTACACTCCATCCAAGG |
| leu1-2s | TCCCCCCGGGCTACCAATCCTGGTGGACTTT | |
| C3 | leu2-2s | TCCCCCCGGGAAAGGAGGCCGCATGTCTGCCCCTAAGAAGATC |
| leu2-2as | GCGAGCTCTTAAGCAAGGATTTTCTTAAC | |
| D1 | leu4-2as | CGGCCTGCAGGATGGTTAAAGAGAGTATTAT |
| leu4-2s | TCCCCCCGGGTTATGCAGAGCCAGATGCCG | |
| D2 | LEU1-S | TCCCCCCGGGAAGGAGACTAATGGTTTACACTCCATCCAA |
| LEU1-AS | GCGAGCTCCTACCAATCCTGGTGGACTTT | |
| F1 | leu1-2 s | CGGCCTGCAGGATGGTTTACACTCCATCCAA |
| leu1-2as | CGCGGATCCCTACCAATCCTGGTGGACTT | |
| G1 | pBL1-as | TCCCCGCGGATTCGGGGTCGTTCACTGGT |
| pBL1-s | CCATCGATAACAACAAGACCCATCATAG | |
| K1 | Kivd-s | AAAACTGCAGATGTATACAGTAGGAGATTACCT |
| Kivd-as | GCTCTAGATTATGATTTATTTTGTTCAGC | |
| H1 | ADH2-s | GCTCTAGAAGGAAACTCAATGTCTATTCCAGAAACTCAA |
| ADH2-as | CGGGGTACCTTATTTAGAAGTGTCAACAACG |
s = sense and as = antisense.
Figure 2The metabolic pathways of 2-keto acid compounds and construction of the biological synthesis pathways in bioengineered strains for producing higher alcohols via fermentation by microbes. A: the common schematic pathways of S. cerevisiae (2-Oxocarboxylic acid metabolism: http://www.genome.jp/dbget-bin/www_bget?pathway:sce01210) and C. crenatum for producing 2-keto acid compounds. The genes LEU2, ILV5, ILV2, ILV3, LEU4, LEU1, BAT1 and BAT2 play a role in the synthesis of 2-keto acids in S. cerevisiae. The genes Cgl 1315, Cgl 1286, Cgl 1271, Cgl 1273, Cgl 1268, Cg1 0248 and Cgl 2204 act as catalysts in the production of 2-keto acids in C. crenatum. LEU2, Cgl 1286:3-isopropylmalate dehydrogenase. ILV5, Cgl 1273:ketoacid reductiove isomerase. ILV2, Cgl 1271:acetyl lactic acid synthase. ILV3, Cgl 1268: dihydroxy acid dehydratase. LEU4, Cg1 0248:2-isopropyl malic acid synthase. LEU1, Cgl 1315: 3-isopropylmalate dehydratase. BAT1, BAT2, Cgl 2204: branched-chain amino acid transaminase. B: construction of the metabolic pathways for higher alcohol production in C. crenatum based on 2-Keto acid pathways; ADH2: Alcohol dehydrogenase; Kivd: alpha-ketoisovalerate decarboxylase. Metabolic pathway A: LEU2-ILV2-ILV5 + KIVD-ADH2; Metabolic pathway B: ILV2-ILV5-ILV3 + KIVD-ADH2; Metabolic pathway C: BAT2 + KIVD-ADH2; Metabolic pathway D: LEU4-LEU1 + KIVD-ADH2; Metabolic pathway E: LEU1 + KIVD-ADH2.
The main components and carbohydrate composition after pretreatment with acid hydrolysis of wild duckweed (before fermentation: 0 h)
|
|
|
|
|
| |
|---|---|---|---|---|---|
|
| |||||
| Dried duckweed | 26.64% | 23.71% | 31.31% | 1.89% | |
| Fresh duckweed | 3.81% | 3.12% | 4.32% | 0.038% | |
|
| |||||
| Pretreatment sample | Glucose | xylose | Galactose | Fructose | Arabinose |
| Dried duckweed | 5.22 ± 0.28 | 1.03 ± 0.055 | 0.49 ± 0.088 | 0.72 ± 0.21 | 0.46 ± 0.24 |
| Fresh duckweed | 0.61 ± 0.14 | 0.094 ± 0.11 | 0.044 ± 0.013 | 0.121 ± 0.016 | 0.094 ± 0.007 |
Content (g) of various components measured in 10 g pretreatment samples. Acid hydrolysis pretreatment method.
Figure 3Genes expression of all recombinant genes for each metabolic pathway in the production host were analyzed using semi-quantitative RT-PCR. Semi-quantitative RT-PCR analysis: Expression profile of all recombinant genes were evaluated using Gel-Pro analyzer 4.0 software.
Figure 4Production of higher alcohols via construction of metabolic pathway A in the bioengineered strain of . (4A) Yield of higher alcohols from glucose. (4B) Yield of higher alcohols from the acid hydrolysates of duckweed. p29-AL + PEC-KA: LEU2 + KIVD-ADH2; p29-ALI + PEC-KA: LEU2-ILV2 + KIVD-ADH2; p29-ALII + PEC-KA: LEU2-ILV2-ILV5 + KIVD-ADH2. CE: C. crenatum CICC 20153. Error bars indicate +/− SD (n = 3). The different letters indicate significant differences based on multiple comparisons for different alcohol products (P < 0.05).
The highest yield of higher alcohols produced via bioengineered strains corresponding to relevant metabolic pathways
|
|
|
|
|
|---|---|---|---|
| Strain with p29-BIII + PEC-KA | 1264.63 a
| 589.43a
| 117.27 a
|
| Strain with p29-ALII + PEC-KA | 499.31 b
| 1026.61 b
| 114.86 a
|
| Strain with p29-DLL + PEC-KA | 306.57 c
| 234.76 c
| 748.35 b
|
the highest yield from glucose; the highest yield from acid hydrolysates of duckweed.
a, b, cdifferent letters in table indicate significant differences based on multiple comparisons (P < 0.05).
Figure 5Production of higher alcohols via construction of metabolic pathway B in the bioengineered strain of . (5A) Yield of higher alcohols from glucose. (5B) Yield of higher alcohols from the acid hydrolysates of duckweed. Error bars indicate +/− SD (n = 3). The different letters indicate significant differences based on multiple comparisons for different alcohol products (P < 0.05). p29-BI + PEC-KA: ILV2 + KIVD-ADH2; p29-BII + PEC-KA: ILV2-ILV5 + KIVD-ADH2; p29-BIII + PEC-KA: ILV2-ILV5-ILV3 + KIVD-ADH2. CE: C. crenatum CICC 20153.
Figure 6Production of higher alcohols via construction of metabolic pathway C in the bioengineered strain of . (6A) Yield of higher alcohols from glucose. (6B) Yield of higher alcohols from the acid hydrolysates of duckweed. p29-CB + PEC-KA: BAT2 + KIVD-ADH2. CE: C. crenatum CICC 20153. Error bars indicate +/− SD (n = 3). The different letters indicate significant differences based on multiple comparisons for different alcohol products (P < 0.05).
Figure 7Production of higher alcohols via construction of metabolic pathway D in the bioengineered strain of . (7A) Yield of higher alcohols from glucose. (7B) Yield of higher alcohols from the acid hydrolysates of duckweed. p29-DL + PEC-KA: LEU4 + KIVD-ADH2; p29-DLL + PEC-KA: LEU4-LEU1 + KIVD-ADH2. CE: C. crenatum CICC 20153. Error bars indicate +/− SD (n = 3). The different letters indicate significant differences based on multiple comparisons for different alcohol products (P < 0.05).
Figure 8Production of higher alcohols via construction of metabolic pathway E in the bioengineered strain of . (8A) Yield of higher alcohols from glucose. (8B) Yield of higher alcohols from the acid hydrolysates of duckweed. p29-FL + PEC-KA: LEU1 + KIVD-ADH2;. CE: C. crenatum CICC 20153. Error bars indicate +/− SD (n = 3). The different letters indicate significant differences based on multiple comparisons for different alcohol products (P < 0.05).
Inhibitor determination from acid hydrolysates of duckweed
|
|
|
|---|---|
| Furfural | 19.65 ± 0.81 |
| Hydroxymethylfurfural (HMF) | 3.89 ± 0.25 |
| Glucuronic acid | ND |
|
| ND |
| Syringic acid | ND |
| Ferulic acid | ND |
ND: Not detected.